Ampio pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Ampio pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced net loss was usd 7.219 million compared to net income of usd 5.801 million a year ago. basic loss per share from continuing operations was usd 0.05 compared to basic earnings per share from continuing operations of usd 0.06 a year ago. diluted loss per share from continuing operations was usd 0.05 compared to usd 0.02 a year ago. for the nine months, net loss was usd 12.610 million compared to net income of usd 32.460 million a year ago. basic loss per share from continuing operations was usd 0.1 compared to basic earnings per share from continuing operations of usd 0.37 a year ago. diluted loss per share from continuing operations was usd 0.1 compared to usd 0.08 a year ago.
AMPE Ratings Summary
AMPE Quant Ranking